National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1380077

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/9/2021

VAERS ID: 1380077
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: Death, COVID-19, SARS-CoV-2 test positive

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-03-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Dementia; Hypertension; Hyperthyroidism; Insulin dependent diabetic; Struma nodosa
Diagnostic Lab Data: Test Date: 20210309; Test Name: SARS-CoV-2 PCR test positive; Test Result: Positive
CDC 'Split Type': HUPFIZER INC2021628091

Write-up: COVID-19 PCR test positive; death; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB: HU-OGYI-348021. A 77-year-old female patient received the first dose of BNT162B2 (Comirnaty, batch/lot number: EJ6790) intramuscularly in the left arm on 03Mar2021 at 8:34 a.m at 0.3 mL single for COVID-19 immunization. Medical history included hyperthyroidism, struma nodosa, insulin dependent diabetes mellitus, hypertension, atrial fibrillation and dementia. The patient was treated in Cardiology until 31Jan2021 due to progressive effort intolerance, dyspnoea, and swelling of feet. The patient was admitted to the Psychiatric Department on 08Feb2021 for examination and medication adjustment, she had not had any psychiatric treatment or examination before. Internal medicine examinations have also found the patient often extremely restless and desoriented. As a result of the drug adjustment, her condition improved. On 03Mar2021 the patient received BNT162B2, no events occurred after vaccination. But on 09Mar2021, before emittion, the patient''s PCR test became positive and her infection was confirmed. COVID-19 symptoms has not occurred during observations. Anxiolytic medication was stopped, but her condition was characterized by negativism, and antihypertensive drugs were also discontinued due to low tension. Laboratory abnormalities have been attempted to be normalized by parenteral medication. Despite the treatment according to the protocol, her condition progressed further, and the patient died among the symptoms of cardiorespiratory insufficiency on 22Mar2021 at 21:40 . Autopsy was not done, the patient''s death was considered to be related to her underlying diseases. Sender''s comment: COVID-19 PCR test became positive after 6 days, and the patient died 19 days after Comirnaty vaccination. Immunity has not developed after the first dose. Autopsy was not done, the patient''s death was considered to be related to her underlying diseases. The case is serious due to hospitalization and fatal outcome. No further information is expected.; Reported Cause(s) of Death: Death; COVID-19

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166